Chi-square analysis confirmed that the frequency of ATM Ser49Cys was significantly higher in a high-risk melanoma cohort (9/384 carriers; n = 7 multiple primary melanoma, n = 2 single primary melanoma) compared to the European cohort (non-Finnish) in GnomAD (p = 0.01). This evidence concerns the gene ATM and melanoma.